BioTech Holding. dk ApS: Financial statements 2021
CVR: 38241672
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BioTech Holding. dk ApS (CVR 38241672) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,045 and a net result of DKK -4,029 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 35,971. The solvency ratio was 8.8%.
- Gross Profit
- DKK -2,045
- Profit/Loss
- DKK -4,029
- Equity
- DKK 35,971
- Total Assets
- DKK 409,785
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2 t. | -4 t. | 36 t. | - |
| 2020 | - | - | 0 | 100 | - |
| 2019 | - | 0 | 0 | 100 | - |
| 2018 | - | 0 | 0 | 100 | - |
| 2017 | 0 | 0 | 0 | 100 | - |
Official annual report
Find more companies like BioTech Holding. dk ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 15, 2021, the company changed its name from BioTech Holding. dk IVS to BioTech Holding. dk ApS.
As of October 8, 2021, Birgit Fredebo Jørgensen is registered as director of BioTech Holding. dk ApS.
As of September 20, 2021, Torben Christensen has stepped down as adm. dir. of BioTech Holding. dk ApS.
BioTech Holding. dk ApS has published its annual report for 2020. The net result was DKK 0.
About BioTech Holding. dk ApS
BioTech Holding. dk ApS was a Danish company of the type Anpartsselskab based in Nykøbing Sj, founded in 2016. The company has been dissolved on 21 January 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BioTech Holding. dk IVS and SymbiCom Holding IVS. In 2021, the company reported a gross profit of DKK -2,045 and a net result of DKK -4,029 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 35,971.